← signals
2026-08-02·NVDA·export restriction
lowdown

Prediction market consensus from August 2, 2026 indicates traders assign only 11% probability that Nvidia resumes...

Prediction market consensus from August 2, 2026 indicates traders assign only 11% probability that Nvidia resumes selling its top GPUs to China by April 1, 2027 (Source 7), and only 19% that Nvidia is allowed to sell B30A to China by 2027 (Source 13).

window 20devidence 24confidence score 91price NVDA $217.55

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate
priced-in check

NVDA has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-08-107d n/a45d n/a90d -1%yahoo

signal brief

Prediction market consensus from August 2, 2026 indicates traders assign only 11% probability that Nvidia resumes selling its top GPUs to China by April 1, 2027 (Source 7), and only 19% that Nvidia is allowed to sell B30A to China by 2027 (Source 13). A separate market sees China's domestic AI chip sector making significant strides, with 74.92% YES on that outcome (Source 9). These markets are speculative, but the consistent low probabilities for renewed China access point to a persistent export-restriction overhang for Nvidia. The H100 compute price market (Source 4) at 3.48% YES for prices above $3.50 appears stale or mislabeled, offering no corroborating demand signal. Data points are crowd-sourced predictions rather than regulatory filings, so confidence is low; however, the direction is clear: continued restrictions are negative for Nvidia's China revenue and support the bear case on AI-chip export policy.

What the sources said:

  • Source 7: "Will Nvidia resume selling its top GPUs to China by April 1, 2027? YES=11.08%"
  • Source 13: "NVIDIA allowed to sell B30A to China by 2027? YES=19.00%"
  • Source 9: "China's AI chip sector make significant strides, planting seeds for eventual decline on Nvidia YES=74.92%"

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.